Acorah Software Products - Accounts Production 15.0.500 false true 31 October 2022 1 November 2021 false 1 November 2022 31 October 2023 31 October 2023 11881579 Mr Wasim Malik iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 11881579 2022-10-31 11881579 2023-10-31 11881579 2022-11-01 2023-10-31 11881579 frs-core:CurrentFinancialInstruments 2023-10-31 11881579 frs-core:Non-currentFinancialInstruments 2023-10-31 11881579 frs-core:ShareCapital 2023-10-31 11881579 frs-core:RetainedEarningsAccumulatedLosses 2023-10-31 11881579 frs-bus:PrivateLimitedCompanyLtd 2022-11-01 2023-10-31 11881579 frs-bus:FilletedAccounts 2022-11-01 2023-10-31 11881579 frs-bus:SmallEntities 2022-11-01 2023-10-31 11881579 frs-bus:AuditExempt-NoAccountantsReport 2022-11-01 2023-10-31 11881579 frs-bus:SmallCompaniesRegimeForAccounts 2022-11-01 2023-10-31 11881579 frs-core:ListedExchangeTraded 2023-10-31 11881579 frs-core:ListedExchangeTraded 2022-10-31 11881579 frs-core:CostValuation frs-core:ListedExchangeTraded 2022-10-31 11881579 frs-core:CostValuation frs-core:ListedExchangeTraded 2023-10-31 11881579 frs-core:ProvisionsForImpairmentInvestments frs-core:ListedExchangeTraded 2022-10-31 11881579 frs-core:ProvisionsForImpairmentInvestments frs-core:ListedExchangeTraded 2023-10-31 11881579 frs-bus:Director1 2022-11-01 2023-10-31 11881579 frs-countries:EnglandWales 2022-11-01 2023-10-31 11881579 2021-10-31 11881579 2022-10-31 11881579 2021-11-01 2022-10-31 11881579 frs-core:CurrentFinancialInstruments 2022-10-31 11881579 frs-core:Non-currentFinancialInstruments 2022-10-31 11881579 frs-core:ShareCapital 2022-10-31 11881579 frs-core:RetainedEarningsAccumulatedLosses 2022-10-31
Registered number: 11881579
Pharma Waltham Limited
Unaudited Financial Statements
For The Year Ended 31 October 2023
UK Tax Accountants
89 Jacobs Well Lane
Wakefield
WF1 3PB
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—4
Page 1
Balance Sheet
Registered number: 11881579
2023 2022
Notes £ £ £ £
FIXED ASSETS
Investments 4 951,709 951,709
951,709 951,709
CURRENT ASSETS
Cash at bank and in hand 2,176 96
2,176 96
Creditors: Amounts Falling Due Within One Year 5 (800 ) (1,600 )
NET CURRENT ASSETS (LIABILITIES) 1,376 (1,504 )
TOTAL ASSETS LESS CURRENT LIABILITIES 953,085 950,205
Creditors: Amounts Falling Due After More Than One Year 6 (707,943 ) (755,429 )
NET ASSETS 245,142 194,776
CAPITAL AND RESERVES
Called up share capital 7 1 1
Profit and Loss Account 245,141 194,775
SHAREHOLDERS' FUNDS 245,142 194,776
Page 1
Page 2
For the year ending 31 October 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Wasim Malik
Director
2nd July 2024
The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Pharma Waltham Limited is a private company, limited by shares, incorporated in England & Wales, registered number 11881579 . The registered office is 3 Patch Wood Court, Newmillerdam, Wakefield, WF2 6TX.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2022: 1)
1 1
4. Investments
Listed
£
Cost
As at 1 November 2022 951,709
As at 31 October 2023 951,709
Provision
As at 1 November 2022 -
As at 31 October 2023 -
Net Book Value
As at 31 October 2023 951,709
As at 1 November 2022 951,709
5. Creditors: Amounts Falling Due Within One Year
2023 2022
£ £
Accruals and deferred income 800 1,600
6. Creditors: Amounts Falling Due After More Than One Year
2023 2022
£ £
Bank loans 698,719 738,205
Bank Loan 2 (Long term liabilities - creditors > 1 year) 9,224 17,224
707,943 755,429
Page 3
Page 4
7. Share Capital
2023 2022
£ £
Allotted, Called up and fully paid 1 1
8. Directors Advances, Credits and Guarantees
Dividends paid to directors
Page 4